TL;DR
This case report details a rare, life-threatening brain abscess caused by the bacterium Providencia rettgeri in an immunocompromised patient. The infection was initially misdiagnosed as a stroke or tumor due to its sudden onset and atypical neuroimaging, but was eventually identified using metagenomic next-generation sequencing (mNGS) and successfully treated with high-dose ampicillin.
What Problem Does This Paper Address?
Brain abscesses are serious localized infections of the brain parenchyma. While many have clear origins (like ear or sinus infections), "cryptogenic" abscesses have no identifiable source and account for up to 43% of cases. These are notoriously difficult to diagnose because they often lack the "classic triad" of symptoms: fever, headache, and focal neurological deficits.
The challenge is amplified in immunocompromised patients, where the immune system's inability to mount a robust response can lead to atypical imaging—specifically, the absence of the "ring enhancement" usually seen on MRIs. This paper highlights the diagnostic hurdles of identifying rare opportunistic pathogens like Providencia rettgeri (more commonly associated with UTIs) when they present as space-occupying brain lesions that mimic strokes or malignant tumors.
Methods
As a clinical case report, the "methods" involve the diagnostic and therapeutic pathway for a 39-year-old male patient:
- Neuroimaging: Sequential use of non-contrasted CT, CT angiography, and multi-modal MRI (including T1-weighted, T2-weighted, FLAIR, Diffusion-Weighted Imaging [DWI], and Apparent Diffusion Coefficient [ADC] maps).
- Laboratory Workup: Standard blood analysis, CSF analysis (cell counts, protein, glucose), and traditional cultures.
- Metagenomic Next-Generation Sequencing (mNGS): When traditional CSF cultures failed to yield a pathogen, the team used mNGS (via WillingMed Technology and the Guangzhou Institute for Respiratory Health). This technique sequences all nucleic acids in a sample and compares them against massive genomic databases to identify non-standard pathogens.
- Pharmacotherapy: Targeted antibiotic treatment based on the mNGS findings and subsequent drug sensitivity assays.
Datasets
This is a single-patient case study; therefore, no large-scale datasets were used for training or evaluation. The "data" consists of the patient's clinical history, the laboratory findings summarized in Table 1, and the longitudinal imaging findings presented in Figure 1.
Key Insights and Ideas
- Pathogen Rarity: Providencia rettgeri is a Gram-negative bacterium rarely seen in intracranial infections. This report expands the known clinical spectrum of this opportunistic pathogen.
- The "Masking" Effect of Immunosuppression: The patient was on immunosuppressants for nephrotic syndrome. The authors suggest this weakened immune state prevented the formation of a typical abscess capsule, leading to the "tumor-like" appearance on MRI rather than the standard ring-enhanced lesion.
- Diagnostic Superiority of mNGS: Traditional cultures are often negative in brain abscess cases (especially if antibiotics were started early). mNGS provided the "aha moment" by detecting 21 sequences of P. rettgeri when all other tests were inconclusive.
- Clinical Mimicry: The sudden onset of speech disorders and hemiplegia (paralysis on one side) led doctors to initially suspect an acute cerebral infarction (stroke), demonstrating that abscesses must remain a differential diagnosis even in the absence of fever.
Key Results
- Identification: mNGS successfully identified P. rettgeri in the CSF on day 18, which was confirmed by a second independent mNGS test.
- Treatment Pivot: After initial failures with ceftriaxone and acyclovir, the treatment was switched to intravenous ampicillin sodium (up to 13.8 g/day).
- Recovery: By day 10 of the new regimen, consciousness and fever improved. By day 28, the patient could walk and lift his arm.
- Follow-up: At the 1-month follow-up, the patient was satisfied with his recovery and showed no new neurological discomfort, despite the persistence of stable (but improved) lesions on MRI.
Limitations and Future Work
- Unknown Origin: Despite extensive testing (chest CT, abdominal ultrasound), the primary source of the P. rettgeri infection remained "cryptogenic." The authors could only speculate on occult hematogenous spread.
- Mechanistic Gap: The paper notes that the specific mechanism by which P. rettgeri crosses the blood-brain barrier (BBB) is still unclear and requires further microbiological research.
- Sample Size: As a single case report, the findings regarding ampicillin efficacy for P. rettgeri brain abscesses cannot be generalized without further study, especially given the high rate of multi-drug resistance in this genus.
Summary updated